VAERS Explorer
Back to explore

Report #2856258

Received Sep 1, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1UNK—

Symptoms (1)

Influenza like illness

Symptom narrative

1st dose of Shingrix that was flu like symptoms; This non-serious case was reported by a nurse via sales rep and described the occurrence of influenza-like symptoms in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced influenza-like symptoms (Verbatim: 1st dose of Shingrix that was flu like symptoms). The outcome of the influenza-like symptoms was resolved (duration 2 days). It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix. It was unknown if the company considered the influenza-like symptoms to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR111186 Additional Information: GSK Receipt Date: 22-AUG-2025 The nurse reported that patient had a reaction to the 1st dose of Shingrix that was flu like symptoms for about 2 days.; Sender's Comments: US-GSK-US2025AMR111186:Shingrix dose 2